FDA Inspection 1068995 — MNJ Institute Of Medical Oncology And Regional Cancer Center
The FDA completed an inspection of MNJ Institute Of Medical Oncology And Regional Cancer Center on Sep 7, 2018 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 7, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Clinical BA/BE